Species-specific detection of porcine xenografts with an antibody against a novel epitope of the lymphocyte homing receptor CD44

Xenotransplantation

Volumn 4, Issue 4, 1997, Pages 252-261

  Oettinger, Henry F ^a   Sullivan, Jennifer A ^a   Crosby, Katherine E ^a   Kelley, Julie A ^a   Jacoby, Douglas B ^a   Dinsmore, Jonathan ^a   Zawadzka, Agatha ^a   Edge, Albert S B ^a  

^a GENVEC INC   (United States)

Author keywords

Cardiomyocyte; CD44; Neural cells; Porcine; Xenotransplantation

Indexed keywords

EID: 0009849122     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3089.1997.tb00190.x     Document Type: Article

References (29)

1. LENSCHOW DJ, ZENG Y, THISTLETHWAITE JR, MONTAG A, BRADY W, GIBSON MG, LINSLEY PS, BLUESTONE JA. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 1992; 257:792.
2. RHIM JA, SANDGREN EP, PALMITER RD, BRINSTER RL. Complete regeneration of mouse liver with xenogeneic hepatocytes. Proc Natl Acad Sci USA 1995; 92:4942.
3. GUNSALUS JR, BRADY DA, COULTER SM, GRAY BM, EDGE ASB. Reduction of serum cholesterol in Watanabe rabbits by xenogeneic hepatocellular transplantation. Nature Med 1997; 3:48.
4. PAKZABAN P, DEACON TW, BURNS LH, DINSMORE J, ISACSON O. A novel mode of immunoprotection of neural xenotransplants: Masking of donor major histocompatibility complex class I enhances transplant survival in the central nervous system. Neuroscience 1995; 65:983.
5. ISACSON O, DEACON TW, PAKZABAN P, GALPERN WR, DINSMORE J, BURNS LH. Transplanted xenogenic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibres. Nature Med 1995; 1:1189.
6. RHIM JA, SANDGREN EP, DEGEN JL, PALMITER RD, BRINSTER RL. Replacement of diseased mouse liver by hepatic cell transplantation. Science 1994; 263:1149.
7. PARKER PONDER K, GUPTA S, LELAND F, DARLINGTON G, FINEGOLD M, DEMAYO J, LEDLEY FD, CHOWDHURY JR, Woo SLC. Mouse hepaotcytes migrate to the liver parenchyma and function indefinitely after intrasplenic transplantation. Proc Natl Acad Sci USA 1991; 88:1217.
8. SORIANO HE, LEWIS D, LEGNER M, BRANDT M, BALEY P, DARLINGTON G, FINEGOLD M, LEDLEY FD. The use of DiI-marked hepatocytes to demonstrate orthotopic, intrahepatic engraftment following hepatocellular transplantation. Transplantation 1992; 54:717.
9. OETTINGER HF, RODRIGUE-WAY A, BOUSQUET J, EDGE ASB. Porcine repeat element DNA: in situ detection of transplanted cells. Cell Transplant 1995; 4:253.
10. HAYNES BF, TELEN MJ, HALE LP, DENNING SM. CD44: A molecule involved in leukocyte adherence and T-cell activation. Immunol Today 1989; 10:423.
11. SHIMIZU Y, NEWMAN W, TANAKA Y, SHAW S. Lymphocyte interactions with endothelial cells. Immunol Today 1992; 13:106.
12. JALKANEN S, BARGATZE RF, TOYOS J, BUTCHER E. Lymphocyte recognition of high endothelium: Antibodies to distinct epitopes of an 85-95 kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J Cell Biol 1987; 105:983.
13. ARUFFO A, STAMENKOVIC I, MELNICK M, UNDERHILL CB, SEED B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990; 61:1303.
14. GINGRAS M, ROUSSEL E, BRUNER JM, BRANCH CD, MOSER R. Comparison of cell adhesion molecule expression between glioblastoma multiforme and autologous normal brain tissue. J Neuroimmunology 1995; 57:143.
15. MORETTO G, Xu RY, KIM SU. CD44 expression in human astrocytes and oligodendrocytes in culture. J Neuropathol Exp Neurol 1993; 52:419.
16. RADOTRA B, MCCORMICK D, CROCKARD A. CD44 plays a role in adhesive interactions between glioma cells and extracellular matrix components. Neuropathol App Neurobiol 1994; 20:399.
17. NAGASAKA S, TANABE KK, BRUNER JM, SAYA H, SAWAYA RE, MORRISON RS. Alternative RNA splicing of the hyaluronic acid receptor CD44 in the normal brain and in brain tumors. J Neurosurg 1995; 82:858.
18. COULDWELL WR, DE TRIBOLET N, ANTEL JP, GAUTHIER T, KUPPNER MC. Adhesion molecules and malignant gliomas: Implications for tumorogenesis. J Neurosurgery 1992; 76:782.
19. ANDERSSONA, MORAN N, GAARDSVOLL H. Characterization of NCAM expression and function in BT4C and BT4Cn glioma cells. Int J Cancer 1991; 47:124.
20. HARN H, LEE H, Ho L, LEE W, DING J. Selective expression of CD44 messenger RNA splice variants in four high grade human brain tumor cell lines. Biochem Mol Biol Int 1994; 33:743.
21. HARLOW E, LANE D. Antibodies: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1988, pp. 139.
22. LAEMMLI UK Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680.
23. YANG H, BINNS RM. Isolation and characterization of the soluble and membrane-bound porcine CD44 molecules. Immunology 1993; 78:547.
24. KRANGEL MS, ORR HT, STROMINGER JL. Assembly and maturation of HLA-A and HLA-B antigens in vivo. Cell 1979; 18:979.
25. MARRET S, DELPECH B, DELPECH A, Asou H, GIRARD N, COUREL M, CHAUZY C, MALVGONNAT C, FESSARD C. Expression and effects of hyaluronan and of the hyaluronan-binding protein hyaluronectin in newborn rat brain glial cell cultures. J Neurochem 1994; 62:1285.
26. YANG H, HUTCHINGS A, BINNS RM. Preparation and reactivities of anti-porcine CD44 monoclonal antibodies. Scand J Immunol 1993; 37:490.
27. ZUCKERMANN FA, BINNS RM, HUSMANN R, YANG H, CARR MM, KIM YB, DAVIS WC, MISFELDT M, LUNNEY JK. Analysis of monoclonal antibodies reactive with porcine CD44 and CD45. Vet Immunol Immunopathol 1994; 43:293.
28. AKIYAMA H, MCGEER PL. Brain microglia constitutively express β-2 integrins. J Neuroimmunol 1990; 30:81.
29. YANG H, BINNS RM CD44 is involved in porcine natural cytotoxicity. Cellular Immunol 1993; 149:227.